Catherine Van Poznak
University of Michigan–Ann Arbor(US)
Publications by Year
Research Areas
Bone health and treatments, Cancer Diagnosis and Treatment, Cancer Treatment and Pharmacology, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research
Most-Cited Works
- → Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research(2007)1,642 cited
- → Activating ESR1 mutations in hormone-resistant metastatic breast cancer(2013)1,143 cited
- → Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline(2016)810 cited
- → Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases(2011)806 cited
- → Bone health in cancer: ESMO Clinical Practice Guidelines(2020)492 cited
- → NCCN Task Force Report: Bone Health in Cancer Care(2013)412 cited
- → Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline(2019)398 cited
- → Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline(2015)390 cited
- → American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer(2011)343 cited
- → TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases(2019)336 cited